Loeb S, Folkvaljon Y, Curnyn C, Robinson D, Bratt O, Stattin P.
“Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden”.
JAMA Oncology. 2016 Oct 20. PMID: 27768168.
Link: https://www.ncbi.nlm.nih.gov/pubmed/27768168
Using nationwide Sweden data, this study showed that by 2014, active surveillance was selected by 91% of very low risk, 74% of low risk and 19% of intermediate risk patients across the country. These rates are the highest yet reported internationally. Dissociating diagnosis from treatment in men with a low risk of progression can decrease the rate of overtreatment.